Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adaptor-related protein complex 1 subunit mu-2 (AP1M2) is a protein component of the heterotetrameric clathrin-associated adaptor protein complex 1 (AP-1), which is involved in protein sorting and vesicle trafficking at the trans-Golgi network (TGN) and endosomes[1][2][5][6]. AP1M2 mediates the recruitment of cargo proteins, selectively recognizing tyrosine-based sorting signals in the cytoplasmic tails of transmembrane proteins[1][2][5]. It is evolutionarily conserved, ubiquitously expressed in eukaryotes, and has been implicated in diverse physiological and pathological processes including thrombosis risk, tumor progression, and immune microenvironment modulation[2][4]. Variations or altered expression of AP1M2 may serve as diagnostic or prognostic biomarkers in certain cancers and may influence disease susceptibility[2][4][6]. **Note:** AP1M2 is not currently classified as a typical druggable therapeutic target such as a receptor, enzyme, or transporter, but rather a structural component of a vesicle trafficking complex with emerging roles in disease mechanisms and biomarker research[1][2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adaptor-related protein complex 1 subunit mu-2 (AP1M2).